# Otitis Media and Relapsing Polychondritis

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the research related to Relapsing Polychondritis, a rare autoimmune disease characterized by recurrent inflammation of cartilage and other tissues. It also encompasses studies on VEXAS syndrome, a recently identified autoinflammatory condition associated with somatic mutations in UBA1. The papers cover various aspects including clinical features, disease activity, therapeutic options, and the role of somatic mutations in these conditions. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t14015 |
| Works | 131 |

## Topic papers all

Showing 15 of 131.

- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of-2/)
- [Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-for-anca-associated-vasculitis/)
- [Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-in-anca-associated-renal-vasculitis/)
- [The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria](https://scholariq.org/papers/the-international-criteria-for-behcet-s-disease-icbd-a-collaborative-study-of-27/)
- [Trial of Tocilizumab in Giant-Cell Arteritis](https://scholariq.org/papers/trial-of-tocilizumab-in-giant-cell-arteritis/)
- [A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies](https://scholariq.org/papers/a-randomized-trial-of-maintenance-therapy-for-vasculitis-associated-with/)
- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of/)
- [2018 update of the EULAR recommendations for the management of Behçet's syndrome](https://scholariq.org/papers/2018-update-of-the-eular-recommendations-for-the-management-of-behcet-s-syndrome/)
- [Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis](https://scholariq.org/papers/efficacy-of-remission-induction-regimens-for-anca-associated-vasculitis/)
- [EULAR recommendations for the management of Behçet disease](https://scholariq.org/papers/eular-recommendations-for-the-management-of-behcet-disease/)
- [EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-anca-associated-vasculitis-2022/)
- [The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease](https://scholariq.org/papers/the-2019-american-college-of-rheumatology-european-league-against-rheumatism-2/)
- [A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis](https://scholariq.org/papers/a-multicenter-randomized-double-blind-placebo-controlled-trial-of-adjuvant/)
- [Ocular manifestations of giant cell arteritis](https://scholariq.org/papers/ocular-manifestations-of-giant-cell-arteritis/)
- [Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease](https://scholariq.org/papers/proposal-for-a-new-set-of-classification-criteria-for-adult-onset-still-disease/)

## Topic primary papers

- [Relapsing polychondritis: An autoimmune disease with many faces](https://scholariq.org/papers/relapsing-polychondritis-an-autoimmune-disease-with-many-faces/)
- [Efficient detection of somatic <i>UBA1</i> variants and clinical scoring system predicting patients with variants in VEXAS syndrome](https://scholariq.org/papers/efficient-detection-of-somatic-i-uba1-i-variants-and-clinical-scoring-system/)
- [Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry](https://scholariq.org/papers/orbital-ocular-inflammatory-involvement-in-vexas-syndrome-data-from-the/)
- [The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico‐histopathologic presentation](https://scholariq.org/papers/the-spectrum-of-skin-disease-in-vexas-syndrome-a-report-of-a-novel-clinico/)
- [P1_185 The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: a Systematic Review and Meta-Analysis](https://scholariq.org/papers/p1-185-the-steroid-tapering-in-anca-vasculitis-evaluation-study-stave-2-a/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.